Best Peptides for Gut Health & Immune: Evidence-Ranked Guide

Gut health and immune function represent an emerging area of peptide research. This category includes two FDA-approved drugs with strong clinical evidence, alongside research compounds like BPC-157 (studied extensively in animal gut models) and KPV (an anti-inflammatory tripeptide generating significant interest). This reference profiles 24 peptides and compounds studied for gut health, gastrointestinal repair, and immune function. Each is ranked by scientific evidence strength, with FDA status clearly marked.

How to Read Evidence Ratings

★★★★★

Strong Clinical Evidence

Multiple high-quality human clinical studies consistently support the effect.

★★★★☆

Good Human Evidence

Meaningful human data, but may be limited by study size or design.

★★★☆☆

Preliminary Human Evidence

Some human research exists, but early, limited, or mixed.

★★☆☆☆

Primarily Preclinical

Evidence from animal or lab studies. Limited or no human data.

★☆☆☆☆

Mechanistic Only

Plausible mechanism, but little direct evidence for the claimed outcome.

★★★★☆ / ★★☆☆☆

Split Rating

Different evidence by use (topical vs. injectable, approved vs. off-label).

Important: Star ratings measure evidence strength, not safety.

Peptide Comparison Table

Every compound in this category, ranked by evidence strength.

Peptide	FDA Status	Evidence	Key Note
Teduglutide (Gattex / Revestive)	FDA-Approved	★★★★★	Strong RCT data for short bowel syndrome
Aprepitant (NK1 antagonist)	FDA-Approved	★★★★★	Strong RCT data for nausea/vomiting
Thymosin Alpha-1 (Zadaxin)	Approved in 35+ countries / Research in US	★★★☆☆	Strong immune evidence internationally; gut-specific data more limited
Larazotide Acetate (AT-1001)	Research (trials completed)	★★★☆☆	Phase II human trials for celiac/gut permeability
Relamorelin	Research (pharma development)	★★★☆☆	Phase II/III gastroparesis data
Ghrelin	Research	★★★☆☆	Multiple human studies on GI motility
GLP-2	Research	★★★☆☆	Meaningful human data (predecessor to teduglutide)
ARA-290 (Cibinetide)	Clinical-Stage Research	★★★☆☆	Phase II human trials
VIP (Vasoactive Intestinal Peptide)	Research	★★★☆☆	Some human GI/immune data; CIRS compounding use
BPC-157	Research	★★☆☆☆	Strong animal GI data; human evidence remains limited
KPV (Lys-Pro-Val)	Research	★★☆☆☆	Primarily preclinical anti-inflammatory data
LL-37 (Cathelicidin)	Research	★★☆☆☆	Some human antimicrobial data; gut-specific claims preclinical
Thymosin Beta-4 (Tb4)	Research	★★☆☆☆	Primarily preclinical
TB-500	Research	★★☆☆☆	Primarily preclinical
Humanin (HN)	Research	★★☆☆☆	Primarily preclinical
HNG (Humanin-Gly)	Research	★★☆☆☆	Primarily preclinical
Substance P	Research	★★☆☆☆	Some human GI data; mixed results
Motilin	Research	★★☆☆☆	Some human GI motility data; no approved form
Neurotensin	Research	★★☆☆☆	Primarily preclinical
PL-18	Research	★☆☆☆☆	Very early/research stage
Alpha-Defensins (HD-5, HD-6)	Research	★☆☆☆☆	Early research; no human trial data for gut claims
Beta-Defensins (HBD-1, HBD-2, HBD-3)	Research	★☆☆☆☆	Early research stage
Cryptdins	Research	★☆☆☆☆	Animal/mechanistic only
Cathelicidins	Research	★☆☆☆☆	Early mechanistic research

Top Compounds

Aprepitant (★★★★★), FDA-Approved

FDA-approved for nausea and vomiting (NK1 receptor antagonist). While not a traditional "gut health" peptide, it demonstrates strong RCT evidence for GI-related symptoms.

Thymosin Alpha-1 (★★★☆☆), Approved in 35+ countries

Internationally approved immune modulator with meaningful clinical data for immune-related conditions. Gut-specific applications are more limited but emerging. Available as Zadaxin in many countries; research-only in the US.

Larazotide Acetate (★★★☆☆), Research

Completed Phase II human trials for celiac disease and gut permeability. One of the few research peptides with actual human clinical trial data for gut-specific applications.

Relamorelin (★★★☆☆), Research

Phase II/III data for gastroparesis. A ghrelin analog studied specifically for GI motility disorders.

Frequently Asked Questions

Is BPC-157 good for gut health?

BPC-157 was originally isolated from gastric juice and has strong preclinical (animal) data for gut healing, including models of IBD, ulcers, and fistula. However, human clinical evidence remains limited (★★☆☆☆). No published human RCTs exist for gut conditions.

What is KPV and does it work?

KPV (Lys-Pro-Val) is a tripeptide fragment of alpha-MSH studied for anti-inflammatory effects, particularly in gut inflammation. Evidence is primarily preclinical (★★☆☆☆). No human clinical trials have been published for gut health applications.

Are there FDA-approved peptides for gut health?

Yes. Teduglutide (Gattex/Revestive) is FDA-approved for short bowel syndrome, and aprepitant is FDA-approved for nausea/vomiting. Both have strong RCT data (★★★★★). Most other peptides in this category are research compounds.

What is Larazotide and is it approved?

Larazotide acetate (AT-1001) is a peptide that completed Phase II human trials for celiac disease and gut permeability disorders. It is rated ★★★☆☆ (preliminary human evidence). It is not FDA-approved but has more human data than most research peptides in this category.

Can peptides heal leaky gut?

"Leaky gut" (intestinal permeability) is studied in research settings. Larazotide acetate has Phase II human data for reducing gut permeability in celiac patients (★★★☆☆). BPC-157 shows strong animal data for gut barrier repair (★★☆☆☆) but no human trials. No peptide is FDA-approved specifically for "leaky gut."

What is Thymosin Alpha-1 used for?

Thymosin Alpha-1 (Zadaxin) is approved in 35+ countries for immune-related conditions including certain infections and cancers. It modulates T-cell function. Gut-specific applications are emerging but more limited than its immune indications. Rated ★★★☆☆; research-only in the US.

Get the Complete Guide

Every compound in this category, fully profiled with mechanisms, evidence ratings, FDA status, and research citations.

Get the Gut Health & Immune Guide, $19.99 →

One-time purchase. Instant download. No subscription.